HighVista Strategies’s Vaxart VXRT Stock Holding History

HighVista Strategies’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-11,600	Closed	-$70K	–	148
2021 Q1	$70K	Hold	11,600	–	–	0.05%	114
2020 Q4	$66K	Hold	11,600	–	–	0.04%	111
2020 Q3	$77K	Buy	+11,600	New	+$103K	0.06%	94

Other funds holding VXRT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HighVista Strategies's VXRT Position: Q2 2021 in Review

HighVista Strategies sold out of Vaxart (VXRT) in Q2 2021, closing a stake of 11,600 shares — an estimated $70K sold.

HighVista Strategies first reported a position in VXRT in Q3 2020 and held it in 3 quarters. The position peaked at $77K in Q3 2020. 143 funds tracked by Wall St. Rank hold VXRT as of Q2 2021.

HighVista Strategies reported no remaining Vaxart position as of Q2 2021 after selling out during the quarter.
HighVista Strategies sold 11,600 Vaxart shares in Q2 2021, an estimated $70K.
HighVista Strategies first reported a position in Vaxart in Q3 2020 and held it in 3 quarters.
HighVista Strategies's Vaxart position peaked at $77K in Q3 2020.
143 funds tracked by Wall St. Rank held Vaxart as of Q2 2021.

Based on HighVista Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.